Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$259,158,157
+$9,754,405 QoQ
Shares Held
2,016,795
-2.7% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#113
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. MRK ranks #3 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,158,157 | 2,016,795 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $249,403,752 | 2,073,354 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $241,154,975 | 2,291,041 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $196,685,926 | 2,343,452 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $180,205,840 | 2,276,476 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $200,764,037 | 2,236,676 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $195,548,830 | 1,965,710 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $232,986,055 | 2,051,656 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $197,308,230 | 1,593,766 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $219,520,332 | 1,663,663 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $207,688,441 | 1,905,049 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $252,405,294 | 2,451,727 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $293,066,829 | 2,539,794 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $282,278,629 | 2,653,244 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $232,608,893 | 2,096,520 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $247,381,508 | 2,872,521 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $233,996,922 | 2,566,600 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $212,147,905 | 2,585,593 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $178,685,010 | 2,331,485 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $176,831,473 | 2,354,300 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $180,548,110 | 2,321,565 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $157,901,990 | 2,048,280 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $38,080,745 | 465,535 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $46,052,119 | 555,179 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $43,062,698 | 556,869 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $49,635,512 | 645,120 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||